Systematic review: Maintenance treatment of gastro-oesophageal reflux disease with proton pump inhibitors taken 'on-demand'

Alimentary Pharmacology and Therapeutics

Volumn 26, Issue 2, 2007, Pages 195-204

  Pace, F ^a   Tonini, M ^b   Pallotta, S ^a   Molteni, P ^a   Porro, G B ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ESOMEPRAZOLE; LANSOPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PLACEBO; PROTON PUMP INHIBITOR; RABEPRAZOLE; RANITIDINE;

CLINICAL TRIAL; COCHRANE LIBRARY; COMPARATIVE STUDY; DOSAGE SCHEDULE COMPARISON; DRUG EFFICACY; ESOPHAGITIS; GASTROESOPHAGEAL REFLUX; HUMAN; MAINTENANCE THERAPY; MEDLINE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SYSTEMATIC REVIEW;

DRUG ADMINISTRATION SCHEDULE; ESOPHAGITIS; GASTROESOPHAGEAL REFLUX; HUMANS; PROTON PUMPS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE;

EID: 34250818636     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2007.03381.x     Document Type: Review

References (36)

1. Pace F, Porro GB. Gastroesophageal reflux disease: a typical spectrum disease (a new conceptual framework is not needed). Am J Gastroenterol 2004 99 : 946 9.
2. Labenz J, Nocon M, Lind T, et al. Prospective follow-up data from the ProGERD study suggest that GERD is not a categorial disease. Am J Gastroenterol 2006 101 : 2457 62.
3. Moayyedi P, Talley N. Gastroesophageal reflux disease. Lancet 2006 367 : 2086 100.
4. Donnellan C, Sharma N, Preston C, Moayyedi P. Medical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux disease. Cochrane Database Syst Rev 2004 4 : CD003245.
5. Lee TJ, Fennerty MB, Howden CW. Systematic review: is there excessive use of proton pump inhibitors in gastro-oesophageal reflux disease? Aliment Pharmacol Ther 2004 20 : 1241 51.
6. Zacny J, Zamakhshary M, Sketris I, Van Zanten V. Systematic review: the efficacy of intermittent and on-demand therapy with histamine H2-receptor antagonists or proton pump inhibitors for gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2005 21 : 1299 312.
7. Hungin AP, Rubin G, O'Flanagan H. Factors influencing compliance in long-term proton pump inhibitor therapy in general practice. Br J Gen Pract 1999 49 : 463 4.
8. Lind T, Havelund T, Lundell L, et al. On-demand therapy with omeprazole for the long-term management of patients with heartburn without oesophagitis - a placebo-controlled randomized trial. Aliment Pharmacol Ther 1999 13 : 907 14.
9. Talley NJ, Lauritsen K, Tunturi-Hihnala H, et al. Esomeprazole 20 mg maintains symptom control in endoscopy-negative gastro-oesophageal reflux disease: a controlled trial of 'on-demand' therapy for 6 months. Aliment Pharmacol Ther 2001 15 : 347 54.
10. Talley NJ, Venables TL, Green JR, et al. Esomeprazole 40 mg and 20 mg is efficacious in the long-term management of patients with endoscopy-negative gastro-oesophageal reflux disease: a placebo-controlled trial of on-demand therapy for 6 months. Eur J Gastroenterol Hepatol 2002 14 : 857 63.
11. Bytzer P, Blum A, De Herdt D, Dubois D. The Trial Investigators. Six-month trial of on-demand rabeprazole 10 mg maintains symptom relief in patients with nonerosive reflux disease. Aliment Pharmacol Ther 2004 20 : 181 8.
12. Johnsson F, Moum B, Vilien M, Grove O, Simren M, Thoring M. On-demand treatment in patients with oesophagitis and reflux symptoms: comparison of lansoprazole and omeprazole. Scand J Gastroenterol 2002 37 : 642 7.
13. Ponce J, Arguello L, Bastida G, Ponce M, Ortiz V, Garrigues V. On-demand therapy with rabeprazole in nonerosive and erosive gastroesophageal reflux disease in clinical practice: effectiveness, health-related quality of life, and patient satisfaction. Dig Dis Sci 2004 49 : 931 6.
14. Juul-Hansen P, Rydning A. On-demand PPI requirements in patients with endoscopy-negative GERD. J Clin Gastroenterol 2004 38 : 746 9.
15. Tsai HH, Chapman R, Shepherd A, et al. Esomeprazole 20 mg on-demand is more acceptable to patients than continuous lansoprazole 15 mg in the long-term maintenance of endoscopy-negative gastro-oesophageal reflux patients: the COMMAND Study. Aliment Pharmacol Ther 2004 15 : 657 65.
16. Hansen N, Bergheim R, Fagertun H, Lund H, Moum B. A randomised prospective study comparing the effectiveness of esomeprazole treatment strategies in clinical practice for 6 months in the management of patients with symptoms of gastroesophageal reflux disease. Int J Clin Pract 2005 59 : 665 71.
17. Hansen AN, Wahlqvist P, Jorgensen E, et al. Six-month management of patients following treatment for gastroesophageal reflux disease symptoms - a Norwegian randomized, prospective study comparing the costs and effectiveness of esomeprazole and ranitidine treatment strategies in a general medical practitioners setting. Int J Clin Pract 2005 59 : 655 64.
18. Kaspari S, Kupcinskas L, Heinze H, Berghofer P. Pantoprazole 20 mg on demand is effective in the long-term management of patients with mild gastro-oesophageal reflux disease. Eur J Gastroenterol Hepatol 2005 17 : 935 41.
19. Bigard MA, Genestin E. Treatment of patients with heartburn without endoscopic evaluation: on-demand treatment after effective continuous administration of lansoprazole 15 mg. Aliment Pharmacol Ther 2005 22 : 635 43.
20. Bour B, Staub JL, Chousterman M, et al. Long-term treatment of gastro-oesophageal reflux disease patients with frequent symptomatic relapses using rabeprazole: 'on-demand' treatment compared with continuous treatment. Aliment Pharmacol Ther 2005 21 : 805 12.
21. Scholten T, Dekkers CP, Schutze K, Korner T, Bohuschke M, Gatz G. On-demand therapy with pantoprazole 20 mg as effective long-term management of reflux disease in patients with mild GERD: the ORION trial. Digestion 2005 72 : 76 85.
22. Sjöstedt S, Befrits R, Sylvan A, et al. Daily treatment with esomeprazole is superior to that taken on-demand for maintenance of healed erosive oesophagitis. Aliment Pharmacol Ther 2005 22 : 183 91.
23. Meineche-Schmidt V, Juhl HH, Ostergaard JE, Luckow A, Hvenegaard A. Costs and efficacy of three different esomeprazole treatment strategies for long-term management of gastrooesophageal reflux symptoms in primary care. Aliment Pharmacol Ther 2004 19 : 907 15.
24. Pace F, Negrini C, Wiklund I, Rossi C, Savarino C. On behalf of the Italian One investigators study group. Aliment Pharmacol Ther 2005 22 : 349 56.
25. Dean BB, Gano AD, Knight K, et al. Effectiveness of proton pump inhibitors in nonerosive reflux disease. Clin Gastroenterol Hepatol 2004 2 : 656 64.
26. Barlow WJ, Orlando RC. The pathogenesis of heartburn in nonerosive reflux disease: a unifying hypothesis. Gastroenterology 2005 128 : 771 8.
27. Fass R, Dickman R. Non-erosive reflux disease (NERD). Pract Gastroenterol 2004 8 : 14 38.
28. Pace F, Bollani S, Molteni P, Bianchi Porro G. Natural history of gastrooesophageal reflux disease without oesophagitis (NERD) - a reappraisal 10 years on. Dig Liver Dis 2004 36 : 111 5.
29. Lagergren J, Bergstrom R, Lindergren A, et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999 340 : 825 31.
30. Isolauri J, Luostarinen M, Isolauri E, et al. Natural course of gastroesophageal reflux disease: 17-22 year follow-up of 60 patients. Am J Gastroenterol 1997 92 : 37 41.
31. Fass R, Ofmann JJ. Gastroesophageal reflux disease - should we adopt a new conceptual framework? Am J Gastroenterol 2002 97 : 1901 8.
32. Zentilin P, Savarino V, Mastracci L, Spaggiari P, Dulbecco P, et al. Reassessment of the diagnostic value of histology in patients with GERD, using multiple biopsy sites and an appropriate control group. Am J Gastroenterol 2005 102 : 2299 306.
33. Ronkainen J, Aro P, Storskrubb T, Johansson SE, Lind T, et al. High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: a Kalixanda study report. Scand J Gastroenterol 2005 40 : 275 85.
34. de Korwin JD, Ducrotte P, Vallot T. New-generation proton pump inhibitors: progress in the treatment of peptic acid diseases. Presse Med 2004 33 : 746 54.
35. Pace F, Manes G, Conio M, Bianchi Porro G. Pre-treatment endoscopy - Pro & Contra: endoscopy is needed before treatment in all patients with gastroesopahgeal reflux disease. Endoscopy 2006 38 : 271 5.
36. Metz DC, Inadomi JM, Howden CW, Veldhuyzen van Zanten SJ, Bytzer P. On-demand therapy for gastroesophageal reflux disease. Am J Gastroenterol 2007 102 : 642 53.